Abstract
It is important to define fluorescence. There are several ways to describe this term: (1) the emission of electromagnetic radiation, especially of visible light, stimulated in a substance by the absorption of incident radiation and persisting only as long as the stimulating radiation is continued. (2) Emitting light during exposure to radiation from an external source. (3) Luminescence that is caused by the absorption of radiation at one wavelength followed by nearly immediate reradiation usually at a different wavelength and that ceases almost at once when the incident radiation stops. The common denominators for this term are a source of radiation, the absorption of this radiation, and the emission of a modified radiation that ends immediately as the source stops emitting radiation. Chemically speaking, fluorescence is brought about by absorption of photons in the singlet ground state promoted to a singlet excited state. The spin of the electron is still paired with the ground state electron. As the excited molecule returns to ground state, it involves the emission of a photon of lower energy, which corresponds to a longer wavelength, than the absorbed photon and therefore lower energy, than the absorbed radiation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grubb C, Crabbe JGS. Fluorescence microscopy in exfoliative cytology. British J Cancer. 1961;15(3):483–8.
Lay Cl, Randall LM. Fluorescent staining for detection of cancer cells in vaginal smears. Surg Forum. 1953;(38th Congress):321–7.
Raymond J. Lanzafame MD, David W. Rogers BS, John O. Nairn MS, Ralph P. Pennino MD, J. Raymond Hinshaw MD, DPhil, FACS1 and Jeffrey R. Blackman BS2 Hematoporphyrin derivative fluorescence: Photographic techniques for the localization of malignant tissue.Lasers in Surgery and Medicine “Volume 6, Issue 3, pages 328–335, 1986.
Rotomskis R, van de Meent EJ, Aartsma TJ, Hoff AJFluorescence spectra of hematoporphyrin and hematoporphyrin-diacetate aggregates in buffer solution Journal of Photochemistry and Photobiology. B, Biology 1989, 3(3):369–377.
Hackney JD, Collier CR. Autofluorescence and fluorochrome staining of alveolar linning. Med Thorac. 1965;22:77–88.
Peck GC, Mack HP. Use of hematoporphyrin fluorescence in biliary and cancer surgery. Annal Surg. 1955;21(3):181–8.
Ahlquist Jr RE, Figge FH. Fluorescence of the extrahepatic biliary system following parenteral hematoporphyrin administration. Surg Forum. 1956;6:356–8.
Kato H, Cortese DA. Early detection of lung cancer by means of hematoporphyrin derivative fluorescence and laser photoradiation. Clin Chest Med. 1985;6(2):237–53.
Ackermann NB, Mc Fee AS. Tetracycline fluorescence in benign and malignant tissues. Surgery. 1963;53:247–52.
Tapp E, Carroll R, Kovács K. Tetracycline fluorescence in experimental tumors. British J Cancer. 1965;19(3):538–46.
Sandlow LJ, Allen HA. The use of tetracycline fluorescence in the detection of gastric malignancy. Ann Intern Med. 1963;58(3):409–13. doi:10.7326/0003-4819-58-3-409.
Sørensen BL, Barlebo H. Ultraviolet light cystoscopy in patients with bladder cancer: one year’s experience. Scand J Urol Nephrol. 1969;3(3):193–200. Departments of Surgery H and Pathology, Gentofte Hospital, Copenhagen, Denmark.
Whitmore Jr WF, Bush IM. Ultraviolet cystoscopy in patients with bladder cancer. Trans Am Assoc Genitourin Surg. 1965;57:149–55.
Málek P, Kolc J, Pultr V, Zástava V. Tetracycline fluorescence test in evaluation of ischemic changes in kidney transplantations. Rozhl Chir. 1966;45(4):252–6.
Cassini MF, da Costa MM. Fluorescence spectroscopy in renal ischemia and reperfusion: noninvasive evaluation of organ viability. Transplant Proc. 2013;45(5):1715–9.
Khutsishili TS, Milaeva MA. The use of the fluorescent method for determining the degree of revascularization of the heart in the surgical treatment of experimental cardiac ischemia. Grudn Khir. 1965;7(6):11–2. Russian.
Somogyi A, Kovács K. Tetracycline fluorescence in experimental necrotizing cardiopathies. Pathol Eur. 1969;4(3):257–64.
Loisance D, Sadony V. Value of fluorescence in the macroscopic delimitation of experimental acute myocardial ischemia before and after revascularization. Arch Mal Coeur Vaiss. 1973;66(6):701–7.
Nessel E, Wiggermann W. The tetracycline fluorescence test in surgery of malignant tumors; rhinolaryngologic experiences. HNO. 1965;13(12):346–9.
Goldhahn WE. Fluorescence studies of brain tumors. Beitr Neurochir. 1966;13:126–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Debonis, D. et al. (2015). Past, Present, and Future of Fluorescence. In: Dip, F., Ishizawa, T., Kokudo, N., Rosenthal, R. (eds) Fluorescence Imaging for Surgeons. Springer, Cham. https://doi.org/10.1007/978-3-319-15678-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-15678-1_2
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15677-4
Online ISBN: 978-3-319-15678-1
eBook Packages: MedicineMedicine (R0)